{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:09:34Z","timestamp":1770041374075,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pheochromocytomas are neoplasms originating from neuroectodermal chromaffin cells leading to excess catecholamine production. They are notorious for causing a triad of headaches, palpitations, and sweats. Though the Menard triad is one to be vigilant of, symptomatic presentation can vary immensely, hence the tumor earning the label \u201cthe great masquerader.\u201d<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a case of pheochromocytoma initially presenting with cortical blindness secondary to posterior reversible encephalopathy syndrome and thrombotic microangiopathy from malignant hypertension. Our patient was seen in our facility less than a week prior to this manifestation and discharged after an unremarkable coronary ischemia work-up. In the outpatient setting, she had been prescribed multiple anti-hypertensives with remarkably elevated blood pressure throughout her hospitalization history.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Pheochromocytoma presenting with malignant hypertension and hypertensive encephalopathy should be expected if left untreated; nonetheless, the precipitation of cortical blindness is rare in the literature. This case contributes an additional vignette to the growing literature revolving adrenal tumors and their symptomatic presentation along with complex management. It also serves to promote increased diagnostic suspicion among clinicians upon evaluating patients with refractory hypertension.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01109-0","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T13:02:36Z","timestamp":1660568556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pheochromocytoma manifesting as cortical blindness secondary to PRES with associated TMA: a case report and literature review"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3359-7176","authenticated-orcid":false,"given":"Sankalp P.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medjine","family":"Jarbath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Saravis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Senada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo A.","family":"Francosadud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"issue":"3","key":"1109_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2478\/enr-2019-0020","volume":"53","author":"FA Farrugia","year":"2019","unstructured":"Farrugia FA, Charalampopoulos A. Pheochromocytoma. Endocr Regul. 2019;53(3):191\u2013212. https:\/\/doi.org\/10.2478\/enr-2019-0020 PMID: 31517632.","journal-title":"Endocr Regul"},{"key":"1109_CR2","first-page":"31","volume":"130 Suppl 2","author":"D Elakovi\u0107","year":"2002","unstructured":"Elakovi\u0107 D, Manojlovi\u0107 D, Milovi\u0107 N. Hirursko lecenje feohromocitoma\u2013nasa iskustva [Surgical treatment of pheochromocytoma\u2013personal experience]. Srp Arh Celok Lek. 2002;130 Suppl 2:31\u20137 Serban. PMID: 12584995.","journal-title":"Srp Arh Celok Lek"},{"key":"1109_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1353.001","volume":"1073","author":"WM Manger","year":"2006","unstructured":"Manger WM. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci. 2006;1073:1\u201320. https:\/\/doi.org\/10.1196\/annals.1353.001.","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"1109_CR4","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1097\/01.hjh.0000251887.01885.54","volume":"24","author":"N Reisch","year":"2006","unstructured":"Reisch N, Peczkowska M, Januszewicz A, Neumann HP. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens. 2006;24(12):2331\u20139. https:\/\/doi.org\/10.1097\/01.hjh.0000251887.01885.54 PMID: 17082709.","journal-title":"J Hypertens"},{"issue":"5","key":"1109_CR5","doi-asserted-by":"publisher","first-page":"e2251","DOI":"10.1210\/clinem\/dgaa965","volume":"106","author":"A Ebbehoj","year":"2021","unstructured":"Ebbehoj A, Stochholm K, Jacobsen SF, Trolle C, Jepsen P, Robaczyk MG, Rasmussen \u00c5K, Feldt-Rasmussen U, Thomsen RW, S\u00f8ndergaard E, Poulsen PL. Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study. J Clin Endocrinol Metab. 2021;106(5):e2251\u201361. https:\/\/doi.org\/10.1210\/clinem\/dgaa965 PMID: 33479747.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1109_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/EC-17-0321","volume":"7","author":"H Falhammar","year":"2018","unstructured":"Falhammar H, Kjellman M, Calissendorff J. Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr Connect. 2018;7(1):186\u201392. https:\/\/doi.org\/10.1530\/EC-17-0321.","journal-title":"Endocr Connect"},{"key":"1109_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40200-016-0226-x","volume":"15","author":"A Soltani","year":"2016","unstructured":"Soltani A, Pourian M, Davani BM. Does this patient have Pheochromocytoma? a systematic review of clinical signs and symptoms [published correction appears in J Diabetes Metab Disord. 2017 Oct 16;16:42]. J Diabetes Metab Disord. 2016;15:6. https:\/\/doi.org\/10.1186\/s40200-016-0226-x Published 2016 Mar 17.","journal-title":"J Diabetes Metab Disord"},{"key":"1109_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","volume":"51","author":"AMA Berends","year":"2018","unstructured":"Berends AMA, Buitenwerf E, de Krijger RR, et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review. Eur J Intern Med. 2018;51:68\u201373. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.015.","journal-title":"Eur J Intern Med"},{"issue":"8","key":"1109_CR9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.5858\/2008-132-1272-PAEPU","volume":"132","author":"AS Tischler","year":"2008","unstructured":"Tischler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med. 2008;132(8):1272\u201384. https:\/\/doi.org\/10.5858\/2008-132-1272-PAEPU.","journal-title":"Arch Pathol Lab Med"},{"issue":"1\u20133","key":"1109_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12020-008-9108-4","volume":"34","author":"EW Lai","year":"2008","unstructured":"Lai EW, Perera SM, Havekes B, et al. Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma. Endocrine. 2008;34(1\u20133):96\u2013100. https:\/\/doi.org\/10.1007\/s12020-008-9108-4.","journal-title":"Endocrine"},{"issue":"6","key":"1109_CR11","first-page":"354","volume":"56","author":"MG Sutton","year":"1981","unstructured":"Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc. 1981;56(6):354\u201360.","journal-title":"Mayo Clin Proc"},{"key":"1109_CR12","unstructured":"Goldman L, Schafer AI. Goldman\u2019s Cecil Medicine E-Book, 24th Edition. Elsevier Health Sciences, 2012. https:\/\/ www.us.elsevierhealth.com\/goldmans-cecil-medicine-e-book-9781437736083.html"},{"key":"1109_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clinl Endocrinol Metab. 2011;96:717\u201325.","journal-title":"J Clinl Endocrinol Metab"},{"key":"1109_CR14","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","volume":"20","author":"L Fishbein","year":"2013","unstructured":"Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be off ered genetic testing. Ann Surg Oncol. 2013;20:1444\u201350.","journal-title":"Ann Surg Oncol"},{"key":"1109_CR15","volume-title":"Diagnostic surgical pathology","author":"SS Sternberg","year":"1999","unstructured":"Sternberg SS, Antonioli DA, Carter D, Mills SE, Oberman HA. Diagnostic surgical pathology. Philadelphia, PA, USA: Lippincott, Williams & Wilkins; 1999."},{"key":"1109_CR16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"an endocrine society clinical practice guideline","year":"2014","unstructured":"an endocrine society clinical practice guideline. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr; Endocrine Society. Pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2014;99:1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"1109_CR17","first-page":"481","volume":"36","author":"MC Megias","year":"2016","unstructured":"Megias MC, Puyol DR, Rodriguez LF, Martinez GLS, Miguel PM. Pheochromocytoma-paraganglioma: Biochemical and genetic diagnosis. [Feocromocitoma-paraganglioma: del diagnostico bioquimico al genetico]. Nefrologia (Madr). 2016;36:481\u20138.","journal-title":"Nefrologia (Madr.)"},{"issue":"Suppl 1","key":"1109_CR18","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1148\/rg.24si045514","volume":"24","author":"KM Elsayes","year":"2004","unstructured":"Elsayes KM, Mukundan G, Narra VR, Lewis JS Jr, Shirkhoda A, Farooki A, Brown JJ. Adrenal masses: MR imaging features with pathologic correlation. Radiographics. 2004;24(Suppl 1):S73\u201386.","journal-title":"Radiographics"},{"key":"1109_CR19","first-page":"419","volume":"52","author":"B Havekes","year":"2008","unstructured":"Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ, Pacak K. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging. 2008;52:419\u201329.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"6","key":"1109_CR20","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342. https:\/\/doi.org\/10.1210\/jc.2014-1498.","journal-title":"J Clin Endocrinol Metab"},{"key":"1109_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Sippel RS, O\u2019Dorisio MS, Vinik AI, Lloyd RV, Pacak K. North American Neuroendocrine Tumor Society (NANETS). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010;39:775\u201383.","journal-title":"Pancreas"},{"key":"1109_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1530\/EJE-11-0162","volume":"165","author":"C Lentschener","year":"2011","unstructured":"Lentschener C, Gaujoux S, Tesniere A, Dousset B. Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal? Eur J Endocrinol. 2011;165:365\u201373.","journal-title":"Eur J Endocrinol"},{"key":"1109_CR23","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.surg.2014.08.020","volume":"156","author":"Y Chen","year":"2014","unstructured":"Chen Y, Hodin RA, Pandolfi C, Ruan DT, McKenzie TJ. Hypoglycemia aft er resection of pheochromocytoma. Surgery. 2014;156:1404\u20139.","journal-title":"Surgery"},{"key":"1109_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00423-015-1287-x","volume":"400","author":"S Sommerey","year":"2015","unstructured":"Sommerey S, Foroghi Y, Chiapponi C, Baumbach SF, Hallfeldt KK, Ladurner R, Gallwas JK. Laparoscopic adrenalectomy\u201310-year experience at a teaching hospital. Langenbecks Arch Surg. 2015;400:341\u20137.","journal-title":"Langenbecks Arch Surg"},{"key":"1109_CR25","first-page":"17","volume":"45","author":"T Hirayama","year":"2015","unstructured":"Hirayama T, Fujita T, et al. Safety and feasibility of laparoscopic adrenalectomy for pheochromocytoma irrespective of tumor size. Th e Kitasato Med J. 2015;45:17\u201320.","journal-title":"Th e Kitasato Med J"},{"key":"1109_CR26","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.surg.2014.08.044","volume":"156","author":"D Press","year":"2014","unstructured":"Press D, Akyuz M, Dural C, Aliyev S, Monteiro R, Mino J, Mitchell J, Hamrahian A, Siperstein A, Berber E. Predictors of recurrence in pheochromocytoma. Surgery. 2014;156:1523\u20138.","journal-title":"Surgery"},{"issue":"3","key":"1109_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1515\/enr-2017-0018","volume":"51","author":"FA Farrugia","year":"2017","unstructured":"Farrugia FA, Martikos G, Tzanetis P, et al. Pheochromocytoma, diagnosis and treatment: Review of the literature. Endocr Regul. 2017;51(3):168\u201381. https:\/\/doi.org\/10.1515\/enr-2017-0018.","journal-title":"Endocr Regul"},{"key":"1109_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.11604\/pamj.2015.20.13.4794","volume":"20","author":"S Younes","year":"2015","unstructured":"Younes S, Abdellaoui M, Zahir F, Benatiya I, Tahri H. Bilateral stellate neuroretinitis revealing a pheochromocytoma. Pan Afr Med J. 2015;20:13. https:\/\/doi.org\/10.11604\/pamj.2015.20.13.4794 Published 2015 Jan 6.","journal-title":"Pan Afr Med J"},{"issue":"28","key":"1109_CR29","doi-asserted-by":"publisher","first-page":"e20918","DOI":"10.1097\/MD.0000000000020918","volume":"99","author":"B Han","year":"2020","unstructured":"Han B, Li Y, Tang M, Wu S, Xu X. Reversible posterior leukoencephalopathy syndrome due to adrenal pheochromocytoma: A case report and literature review. Medicine (Baltimore). 2020;99(28):e20918. https:\/\/doi.org\/10.1097\/MD.0000000000020918.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1109_CR30","doi-asserted-by":"publisher","first-page":"ytaa513","DOI":"10.1093\/ehjcr\/ytaa513","volume":"5","author":"C Domined\u00f2","year":"2021","unstructured":"Domined\u00f2 C, D\u2019Avino E, Martinotti A, Cingolani E. A rare pheochromocytoma complicated by cardiogenic shock and posterior reversible encephalopathy syndrome: case report. Eur Heart J Case Rep. 2021;5(2):ytaa513. https:\/\/doi.org\/10.1093\/ehjcr\/ytaa513 Published 2021 Jan 12.","journal-title":"Eur Heart J Case Rep."},{"issue":"6","key":"1109_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.30476\/ijms.2020.85052.1486","volume":"45","author":"A Ghorbani","year":"2020","unstructured":"Ghorbani A, Reza OV. Atypical Posterior Reversible Encephalopathy Syndrome as the First Presentation of a Pheochromocytoma: A Case Report. Iran J Med Sci. 2020;45(6):485\u201390. https:\/\/doi.org\/10.30476\/ijms.2020.85052.1486.","journal-title":"Iran J Med Sci"},{"key":"1109_CR32","doi-asserted-by":"publisher","first-page":"2397638","DOI":"10.1155\/2019\/2397638","volume":"2019","author":"N Sharma","year":"2019","unstructured":"Sharma N, Ravi D, Khan M, Sravanthi MV, Aloysius MM. Microangiopathic Hemolytic Anemia and Fulminant Renal Failure: A Rare Manifestation of Pheochromocytoma. Case Rep Endocrinol. 2019;2019:2397638. https:\/\/doi.org\/10.1155\/2019\/2397638.","journal-title":"Case Rep Endocrinol."},{"issue":"8","key":"1109_CR33","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.amjhyper.2007.02.018","volume":"20","author":"B-JH van den Born","year":"2007","unstructured":"van den Born B-JH, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens. 2007;20(8):900\u20136.","journal-title":"Am J Hypertens"},{"key":"1109_CR34","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ndt\/gfh742","volume":"20","author":"MJ Gillett","year":"2005","unstructured":"Gillett MJ, Arenson RV, Yew MK, et al. Diagnostic challenges associated with a complex case of cystic phaeochromocytoma presenting with malignant hypertension, microangiopathic haemolysis and acute renal failure. Nephrol Dial Transplant. 2005;20:1014.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01109-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T13:03:10Z","timestamp":1660568590000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01109-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1109"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01109-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"8 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}